132 related articles for article (PubMed ID: 8032151)
1. Genetic polymorphism of cytochrome P450. Functional consequences and possible relationship to disease and alcohol toxicity.
Ingelman-Sundberg M; Johansson I; Persson I; Oscarson M; Hu Y; Bertilsson L; Dahl ML; Sjöqvist F
EXS; 1994; 71():197-207. PubMed ID: 8032151
[TBL] [Abstract][Full Text] [Related]
2. Ethanol-inducible cytochrome P4502E1: genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease.
Ingelman-Sundberg M; Johansson I; Yin H; Terelius Y; Eliasson E; Clot P; Albano E
Alcohol; 1993; 10(6):447-52. PubMed ID: 8123198
[TBL] [Abstract][Full Text] [Related]
3. Expression, induction, and catalytic activity of the ethanol-inducible cytochrome P450 (CYP2E1) in human fetal liver and hepatocytes.
Carpenter SP; Lasker JM; Raucy JL
Mol Pharmacol; 1996 Feb; 49(2):260-8. PubMed ID: 8632758
[TBL] [Abstract][Full Text] [Related]
4. Induction mechanisms of cytochrome P450 2E1 in liver: interplay between ethanol treatment and starvation.
Hu Y; Ingelman-Sundberg M; Lindros KO
Biochem Pharmacol; 1995 Jul; 50(2):155-61. PubMed ID: 7632158
[TBL] [Abstract][Full Text] [Related]
5. Acetaminophen metabolism in patients with different cytochrome P-4502E1 genotypes.
Ueshima Y; Tsutsumi M; Takase S; Matsuda Y; Kawahara H
Alcohol Clin Exp Res; 1996 Feb; 20(1 Suppl):25A-28A. PubMed ID: 8659683
[TBL] [Abstract][Full Text] [Related]
6. Modulation of experimental alcohol-induced liver disease by cytochrome P450 2E1 inhibitors.
Morimoto M; Hagbjörk AL; Wan YJ; Fu PC; Clot P; Albano E; Ingelman-Sundberg M; French SW
Hepatology; 1995 Jun; 21(6):1610-7. PubMed ID: 7768506
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphism of cytochromes P450 1A1, 2D6 and 2E1: regulation and toxicological significance.
Rannug A; Alexandrie AK; Persson I; Ingelman-Sundberg M
J Occup Environ Med; 1995 Jan; 37(1):25-36. PubMed ID: 7620940
[TBL] [Abstract][Full Text] [Related]
8. Early alcoholic liver injury: formation of protein adducts with acetaldehyde and lipid peroxidation products, and expression of CYP2E1 and CYP3A.
Niemelä O; Parkkila S; Pasanen M; Iimuro Y; Bradford B; Thurman RG
Alcohol Clin Exp Res; 1998 Dec; 22(9):2118-24. PubMed ID: 9884160
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphism of cytochrome P4502E1 and risk of alcoholic liver disease in Caucasians.
Pirmohamed M; Kitteringham NR; Quest LJ; Allott RL; Green VJ; Gilmore IT; Park BK
Pharmacogenetics; 1995 Dec; 5(6):351-7. PubMed ID: 8747406
[TBL] [Abstract][Full Text] [Related]
10. Expression of the peroxisome proliferator-activated receptor gene is decreased in experimental alcoholic liver disease.
Wan YJ; Morimoto M; Thurman RG; Bojes HK; French SW
Life Sci; 1995; 56(5):307-17. PubMed ID: 7837930
[TBL] [Abstract][Full Text] [Related]
11. Activation of alkylhydrazines to free radical intermediates by ethanol-inducible cytochrome P-4502E1 (CYP2E1).
Albano E; Comoglio A; Clot P; Iannone A; Tomasi A; Ingelman-Sundberg M
Biochim Biophys Acta; 1995 Apr; 1243(3):414-20. PubMed ID: 7727516
[TBL] [Abstract][Full Text] [Related]
12. An investigation of whether polymorphisms of cytochrome P4502E1 are genetic markers of susceptibility to alcoholic end-stage organ damage in a Chinese population.
Chao YC; Young TH; Chang WK; Tang HS; Hsu CT
Hepatology; 1995 Nov; 22(5):1409-14. PubMed ID: 7590656
[TBL] [Abstract][Full Text] [Related]
13. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1.
Hyland R; Gescher A; Thummel K; Schiller C; Jheeta P; Mynett K; Smith AW; Mráz J
Mol Pharmacol; 1992 Feb; 41(2):259-66. PubMed ID: 1538706
[TBL] [Abstract][Full Text] [Related]
14. Genotypes of ALDH2 related to liver and pulmonary diseases and other genetic factors related to alcoholic liver disease.
Takada A; Tsutsumi M; Kobayashi Y
Alcohol Alcohol; 1994 Nov; 29(6):719-27. PubMed ID: 7695791
[TBL] [Abstract][Full Text] [Related]
15. Zonation of acetaminophen metabolism and cytochrome P450 2E1-mediated toxicity studied in isolated periportal and perivenous hepatocytes.
Anundi I; Lähteenmäki T; Rundgren M; Moldeus P; Lindros KO
Biochem Pharmacol; 1993 Mar; 45(6):1251-9. PubMed ID: 8466546
[TBL] [Abstract][Full Text] [Related]
16. Ethanol-inducible cytochrome P450 (CYP2E1): biochemistry, molecular biology and clinical relevance: 1996 update.
Song BJ
Alcohol Clin Exp Res; 1996 Nov; 20(8 Suppl):138A-146A. PubMed ID: 8947253
[No Abstract] [Full Text] [Related]
17. Characterization of cytochrome P450 2E1 induction in a rat hepatoma FGC-4 cell model by ethanol.
McGehee RE; Ronis MJ; Cowherd RM; Ingelman-Sundberg M; Badger TM
Biochem Pharmacol; 1994 Nov; 48(9):1823-33. PubMed ID: 7980652
[TBL] [Abstract][Full Text] [Related]
18. Use of lymphocytes for assessing ethanol-mediated alterations in the expression of hepatic cytochrome P4502E1.
Raucy JL; Curley G; Carpenter SP
Alcohol Clin Exp Res; 1995 Dec; 19(6):1369-75. PubMed ID: 8749797
[TBL] [Abstract][Full Text] [Related]
19. Cytochromes P450 2A6, 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases.
Niemelä O; Parkkila S; Juvonen RO; Viitala K; Gelboin HV; Pasanen M
J Hepatol; 2000 Dec; 33(6):893-901. PubMed ID: 11131450
[TBL] [Abstract][Full Text] [Related]
20. Microsomal ethanol oxidizing system activity by human hepatic cytochrome P450s.
Asai H; Imaoka S; Kuroki T; Monna T; Funae Y
J Pharmacol Exp Ther; 1996 May; 277(2):1004-9. PubMed ID: 8627510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
